[Nuclear factor-kappaB and inflammatory bowel disease]

[Article in Chinese]

Affiliations

Review

[Article in Chinese]

Hua-tian Gan et al. Zhonghua Nei Ke Za Zhi. 2003 Feb.

. 2003 Feb;42(2):137-9.

No abstract available

Similar articles

NF-kappaB signaling: pros and cons of altering NF-kappaB as a therapeutic approach.
Egan LJ, Toruner M. Egan LJ, et al. Ann N Y Acad Sci. 2006 Aug;1072:114-22. doi: 10.1196/annals.1326.009. Ann N Y Acad Sci. 2006. PMID: 17057194 Review.
The complicated path to true causes of disease: role of nuclear factor kappaB in inflammatory bowel disease.
Schreiber S. Schreiber S. Gut. 2005 Apr;54(4):444-5. doi: 10.1136/gut.2004.051797. Gut. 2005. PMID: 15753521 Free PMC article. No abstract available.
A gut feeling of the PXR, PPAR and NF-kappaB connection.
Wahli W. Wahli W. J Intern Med. 2008 Jun;263(6):613-9. doi: 10.1111/j.1365-2796.2008.01951.x. J Intern Med. 2008. PMID: 18479261 Review.
Targeting Smads to restore transforming growth factor-beta signaling and regulatory T-cell function in inflammatory bowel disease.
Nguyen DD, Snapper SB. Nguyen DD, et al. Gastroenterology. 2009 Apr;136(4):1161-4. doi: 10.1053/j.gastro.2009.02.024. Epub 2009 Feb 23. Gastroenterology. 2009. PMID: 19236965 No abstract available.
Of mice and men: what to learn about human inflammatory bowel disease from genetic analysis of murine inflammation.
Schreiber S. Schreiber S. Gastroenterology. 2005 Nov;129(5):1782-4. doi: 10.1053/j.gastro.2005.09.052. Gastroenterology. 2005. PMID: 16285973 No abstract available.